China Medical System Holdings Ltd Financials

Market Capitalization HK$32.45 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	17.04
Forward PE	14.16
Price to Sales TTM	HK$4.02
Price to Book MRQ	HK$1.65
Enterprise to Revenue	3.32
Enterprise to EBITDA	13.74

Financial Reports as of Jun. 30, 2018

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2018-06-30
Profit Margin	21.00%
Operating Margin	20.84%
Return on Assets TTM	5.58%
Return on Equity TTM	9.91%

Income Statement

Revenue TTM	HK$8,754,121,856
Revenue per Share TTM	HK$3.25
Quarterly Revenue Growth	10.80%
Gross Profit TTM	HK$6,256,721,195
EBITDA	HK$2,673,166,059
Net Income to Common TTM	HK$1,838,321,971
Diluted EPS TTM	HK$0.76
Quarterly Earnings Growth YoY	3.40%

Balance Sheet

Total Cash MRQ	HK$6,647,174,385
Total Cash per Share MRQ	HK$2.47
Total Debt MRQ	HK$
Total Debt to Equity MRQ	4.36
Current Ratio MRQ	5.78
Book Value per Share MRQ	HK$7.83

Cash Flow

Operating Cash Flow TTM	HK$1,060,887,059
Levered Free Cash Flow TTM	HK$502,540,971

0867 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	2,439,529,000
Float Shares	1,175,427,913
Avg 10 Volume	3,222,251
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	50.91%
% Held by Institutions	23.52%

Stock Price Summary

Beta	1.28
Fifty Two Week Low	HK$6.71
Fifty Two Week High	HK$15.63
Fifty Two Week Change	45.92%
Day 50 MA	HK$13.48
Day 200 MA	HK$12.00

Dividends and Splits

Forward Annual Dividend Rate	HK$0.34
Forward Annual Dividend Yield	2.61%
Trailing Annual Dividend Rate	HK$0.30
Trailing Annual Dividend Yield	2.27%
Payout Ratio	39.26%
Dividend Date
Ex Dividend Date	2025-08-29
Last Split Factor
Last Split Date	2012-04-27